JOHNSON JOHN - Insider Non-Derivative Transactions at Xeris Biopharma Holdings, Inc. (XERS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 5, 2024, JOHNSON JOHN's relationship to Xeris Biopharma Holdings, Inc. (XERS) is Director, and currently has 890,983 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other XERS insiders.
Data Source: SEC.
JOHNSON JOHN - Insider Non-Derivative Transactions of XERS Common Stock
JOHNSON JOHN - Insider Non-Derivative Transactions at XERS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 6, 2024 | Acquisition -- (Common Stock) | 50000 | 0 | 890983 |
| Mar 19, 2024 | M -- (Common Stock) | 215600 | 1.99 | 751412 |
| Mar 16, 2024 | J -- (Common Stock) | 89571 | 0 | 840983 |
| Jun 8, 2023 | Acquisition -- (Common Stock) | 42500 | 0 | 535812 |